An Outbreak of Multidrug-Resistant Tuberculosis among Hospitalized Patients with the Acquired Immunodeficiency Syndrome

New England Journal of Medicine

Volumn 326, Issue 23, 1992, Pages 1514-1521

  Edlin, Brian R ^a   Tokars, Jerome I ^b   Grieco, Michael H ^d   Crawford, Jack T ^a   Williams, Julie ^d   Sordillo, Emelia M ^d   Ong, Kenneth R ^d   Kilburn, James O ^a   Dooley, Samuel W ^c   Castro, Kenneth G ^a   Jarvis, William R ^b   Holmberg, Scott D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; IMMUNE RESPONSE; MALE; MORBIDITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; TUBERCULOSIS;

EID: 0026752606     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199206043262302     Document Type: Article

References (23)

1. Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324: 1644–50.
2. Di Peni G, Cruciani M, Danzi MC, et al. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 1989; 2: 1502–4.
3. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons — Florida and New York, 1988–1991. MMWR 1991; 40: 585–91.
4. Antituberculosis chemotherapy and drug susceptibility testing. In: Kent PT, Kubica GP. Public health mycobacteriology: a guide for the level III laboratory. Atlanta: Public Health Service, 1985:159–84.
5. Cave MD, Eisenach KD, McDermott PF, Bates JH, Crawford JT. IS6110: conservation of sequence in the Mycobacterium tuberculosis complex and its utilization in DNA fingerprinting. Mol Cell Probes 1991; 5: 73–80.
6. Lubin JH. A computer program for the analysis of matched case–control studies. Comput Biomed Res 1981; 14: 138–43.
7. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545–50.
8. Des Prez RM, Heim CR. Mycobacterium tuberculosis. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practices of infectious diseases. 3rd ed. New York: Churchill Livingstone, 1990:1881.
9. Braun MM, Truman BI, Maguire B, et al. Increasing incidence of tuberculosis in a prison inmate population. JAMA 1989; 261: 393–7.
10. Pelletier AR, DiFerdinando G, Greenberg A, Sosin D, Jones W, Bloch A. Tuberculosis in a county jail, New York. In: Abstracts of the 40th Annual Conference of the Epidemic Intelligence Service, Atlanta, April 8–12, 1991. Washington, D.C.: Department of Health and Human Services, 1991:43.
11. Valway SE, Richards S, Kovacovich J, et al. Transmission of multidrugresistant tuberculosis among inmates in prisons, New York State, 1991. In: Abstracts of the 41st Annual Conference of the Epidemic Intelligence Service, Atlanta, April 6–10, 1992. Washington, D.C.: Department of Health and Human Services, 1992:30.
12. Transmission of multidrug-resistant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility — Michigan. MMWR 1991; 40: 129–31.
13. Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus — an analysis using restriction-fragmentlength polymorphisms. N Engl J Med 1992; 326: 231–5.
14. Drug-resistant tuberculosis among the homeless — Boston. MMWR 1985; 34: 429–31.
15. Torres RA, Mani S, Altholz J, Brickner PW. Human immunodeficiency virus infection among homeless men in a New York City shelter: association with Mycobacterium tuberculosis infection. Arch Intern Med 1990; 150: 2030–6.
16. McAdam JM, Brickner PW, Scharer LL, Crocco JA, Duff AE. The spectrum of tuberculosis in a New York city men's shelter clinic (1982–1988). Chest 1990; 97: 798–805.
17. Erratum, Chest 1991; 99: 792.
18. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR 1990; 39: Suppl RR-17.
19. Salomon N, Perlman DC, Depalo VA, Kolokathis A, Wilets I. A significant rise in primary drug resistant tuberculosis. In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, September 29—October 2, 1991. Washington, D.C.: American Society for Microbiology, 1991:152. abstract.
20. Shafer RW, Chirgwin KD, Glatt AE, Dahdouh MA, Landesman SH, Suster B. HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS. AIDS 1991; 5: 399–405.
21. Monno L, Angarano G, Carbonara S, et al. Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients. Lancet 1991; 337: 852.
22. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986; 134: 355–63.
23. Iseman MD, Madsen LA. Drug-resistant tuberculosis. Clin Chest Med 1989; 10: 341–53.